Back to Woodline Partners LP Woodline Partners LP

PFEPFE

Showing 8 of 24 quarters

Position history for Woodline Partners LPWoodline Partners LP's holdings in Pfizer, Inc.

Yes. Woodline Partners holds 2,154,713 shares of PFE (Pfizer), worth $51.9M, as of its Q2 2026 13F filing. It increased the position by 120,871 shares (+5.9%) from Q1 2026. Woodline Partners has held PFE since Q1 2021, across 22 quarterly 13F filings. PFE is 0.2% of Woodline Partners' reported 13F portfolio.

Current Value

$51.9M

Current Shares

2.2M

Total Value Change

+$19.3M

Total Shares Change

+1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.2M
+5.9%
$51.9M0.2%$23.67
37
2026-Q1
Increased
2M
+24.9%
$57.1M0.2%$27.15
43
2025-Q4
Increased
1.6M
+11.7%
$40.5M0.2%$23.68
39
2025-Q3
Increased
1.5M
+2.3%
$37.2M0.2%$23.81
35
2025-Q2
Increased
1.4M
+18.5%
$34.6M0.2%$22.27
41
2025-Q1
Decreased
1.2M
-8.7%
$30.5M0.2%$22.84
0
2024-Q4
Increased
1.3M
+17.0%
$35M0.2%$23.53
40
2024-Q3
Increased
1.1M
0.0%
$32.6M0.3%$25.27
34

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used